Literature DB >> 25075470

A home-brew real-time PCR assay for reliable detection and quantification of mature miR-122.

Mahmood Naderi1, Hossein Abdul Tehrani, Masoud Soleimani, Iman Shabani, Seyed Mahmoud Hashemi.   

Abstract

miR-122 is a liver-specific miRNA that has significant gene expression alterations in response to specific pathophysiological circumstances of liver such as drug-induced liver injury, hepatocellular carcinoma, and hepatitis B and C virus infections. Therefore, accurate and precise quantification of miR-122 is very important for clinical diagnostics. However, because of the lack of in vitro diagnostics assays for miR-122 detection and quantification of the existence of an open-source assay could inevitably provide external evaluation by other researchers and the chance of promoting the assay when required. The aim of this study was to develop a Taqman real-time polymerase chain reaction assay, which is capable of robust and reliable quantification of miR-122 in different sample types. We used stem loop methodology to design a specific Taqman real-time polymerase chain reaction assay for miR-122. This technique enabled us to reliably and reproducibly quantify short-length oligonucleotides such as miR-122. The specificity, sensitivity, interassay and intra-assay, and the dynamic range of the assay were experimentally determined by their respective methodology. The assay had a linear dynamic range of 3E to 4.8E miR-122 copies/reaction and the limit of detection was determined to be between 960 and 192 copies/reaction with 95% confidence interval. The assay gave a coefficient of variation for the Ct values of <1.4% and 0.78% for intra-assay and interassay, respectively. Taking into account that miR-122 is expressed in >50,000 copies per hepatocyte, this assay is able to suffice the need for reliable detection and quantification of this miRNA. Therefore, this study can be considered as a start point for standardizing miR-122 quantification.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25075470     DOI: 10.1097/PAI.0000000000000125

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

Review 1.  Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies.

Authors:  Alieh Gholaminejad; Hossein Abdul Tehrani; Mohammad Gholami Fesharaki
Journal:  J Nephrol       Date:  2018-07-17       Impact factor: 3.902

2.  Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.

Authors:  Hilda Samimi; Vahid Haghpanah; Shiva Irani; Ehsan Arefian; Alireza Naderi Sohi; Parviz Fallah; Masoud Soleimani
Journal:  Daru       Date:  2019-05-10       Impact factor: 3.117

3.  Effects of miR-21 downregulation and silibinin treatment in breast cancer cell lines.

Authors:  Zohreh Jahanafrooz; Nasrin Motamed; Behnaz Bakhshandeh
Journal:  Cytotechnology       Date:  2017-03-20       Impact factor: 2.058

4.  Circulating miRNAs can serve as potential diagnostic biomarkers in chronic myelogenous leukemia patients.

Authors:  Farid Keramati; Arefeh Jafarian; Adele Soltani; Ehsan Javandoost; Mojtaba Mollaei; Parviz Fallah
Journal:  Leuk Res Rep       Date:  2021-07-01

5.  Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.

Authors:  Vahid Haghpanah; Parviz Fallah; Rezvan Tavakoli; Mahmood Naderi; Hilda Samimi; Masoud Soleimani; Bagher Larijani
Journal:  Tumour Biol       Date:  2015-08-20

6.  The miR-142 Suppresses U-87 Glioblastoma Cell Growth by Targeting EGFR Oncogenic Signaling Pathway.

Authors:  Fatemeh Gheidari; Ehsan Arefian; Fatemeh Jamshidi Adegani; Fereshteh Fallah Atanaki; Masoud Soleimani
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

7.  miRNA-Dependent Regulation of AKT1 Phosphorylation.

Authors:  Mallory I Frederick; Tarana Siddika; Pengcheng Zhang; Nileeka Balasuriya; Matthew A Turk; Patrick O'Donoghue; Ilka U Heinemann
Journal:  Cells       Date:  2022-02-26       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.